---
nav_exclude: true
title: 'å‚³æŸ“ç—…å¨è„…é€±å ± 2026-W09'
layout: default
date: 2026-02-26
lastReviewed: 2026-02-26
reviewedBy: EpiAlert AI ç·¨è¼¯
datePublished: '2026-02-25T12:00:00+08:00'
dateModified: '2026-02-26T23:00:00+08:00'
seo:
  meta:
    title: 'å‚³æŸ“ç—…å¨è„…é€±å ± 2026-W09 | EpiAlert ç–«æƒ…å¿«è¨Š'
    description: 'æœ¬é€±é‡é»ï¼šç™»é©ç†±å¢ƒå¤–ç§»å…¥é¢¨éšªè­¦ç¤ºã€è«¾ç¾…ç—…æ¯’å…¨çƒé«˜å³°ã€å°ç£æµæ„Ÿæ”¿ç­–èª¿æ•´ã€è‹±åœ‹å¸¶ç‹€ç–±ç–¹ç–«è‹—æ¥ç¨®å‘¼ç±²ã€2026-2027æµæ„Ÿè¨ˆç•«ç™¼å¸ƒã€‚'
    og:title: 'å‚³æŸ“ç—…å¨è„…é€±å ± 2026-W09 | EpiAlert'
    og:description: 'ç™»é©ç†±å¢ƒå¤–ç§»å…¥é¢¨éšªä¸Šå‡ã€è«¾ç¾…ç—…æ¯’ç–«æƒ…é”è¿‘äº”å¹´é«˜å³°ã€å°ç£å…¬è²»ç–«è‹—æ¥ç¨®è²»èª¿æ•´ã€è‹±åœ‹å‘¼ç±²å¸¶ç‹€ç–±ç–¹ç–«è‹—æ¥ç¨®ã€‚'
    og:type: 'article'
    og:url: 'https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W09'
    og:image: 'https://epialert.weiqi.kids/assets/images/logo.png'
    article:published_time: '2026-02-25T12:00:00+08:00'
    article:modified_time: '2026-02-26T23:00:00+08:00'
    twitter:card: 'summary_large_image'
  json_ld:
    '@context': 'https://schema.org'
    '@graph':
      - '@type': 'WebPage'
        '@id': 'https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W09#webpage'
        url: 'https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W09'
        name: 'å‚³æŸ“ç—…å¨è„…é€±å ± 2026-W09'
        description: 'ç™»é©ç†±å¢ƒå¤–ç§»å…¥é¢¨éšªã€è«¾ç¾…ç—…æ¯’å…¨çƒé«˜å³°ã€å¸¶ç‹€ç–±ç–¹ç–«è‹—æ¥ç¨®ã€2026-2027æµæ„Ÿè¨ˆç•«'
        inLanguage: 'zh-TW'
        isPartOf:
          '@id': 'https://epialert.weiqi.kids#website'
        primaryImageOfPage:
          '@type': 'ImageObject'
          url: 'https://epialert.weiqi.kids/assets/images/logo.png'
        datePublished: '2026-02-25T12:00:00+08:00'
        dateModified: '2026-02-26T23:00:00+08:00'
        speakable:
          '@type': 'SpeakableSpecification'
          cssSelector:
            - '.article-summary'
            - '.speakable-content'
            - '.key-takeaway'
            - '.key-answer'
            - '.expert-quote'
            - '.actionable-steps li'
            - '.faq-answer-content'
      - '@type': 'Article'
        '@id': 'https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W09#article'
        mainEntityOfPage:
          '@id': 'https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W09#webpage'
        headline: 'å‚³æŸ“ç—…å¨è„…é€±å ± 2026-W09'
        alternativeHeadline: 'Infectious Disease Threats Weekly Report 2026-W09'
        description: 'æœ¬é€±é‡é»ï¼šç™»é©ç†±å¢ƒå¤–ç§»å…¥é¢¨éšªã€è«¾ç¾…ç—…æ¯’å…¨çƒé«˜å³°ã€å¸¶ç‹€ç–±ç–¹ç–«è‹—æ¥ç¨®å‘¼ç±²ã€2026-2027æµæ„Ÿè¨ˆç•«'
        image:
          '@type': 'ImageObject'
          url: 'https://epialert.weiqi.kids/assets/images/logo.png'
          width: 1200
          height: 630
        author:
          '@id': 'https://epialert.weiqi.kids/about#person'
        publisher:
          '@id': 'https://epialert.weiqi.kids#organization'
        datePublished: '2026-02-25T12:00:00+08:00'
        dateModified: '2026-02-26T23:00:00+08:00'
        articleSection: 'é€±å ±'
        keywords: 'ç™»é©ç†±, dengue, è«¾ç¾…ç—…æ¯’, norovirus, æµæ„Ÿ, influenza, å¸¶ç‹€ç–±ç–¹, shingles, Shingrix, å‚³æŸ“ç—…ç›£æ¸¬, ç–«æƒ…é€±å ±'
        wordCount: 6500
        inLanguage: 'zh-TW'
        isAccessibleForFree: true
      - '@type': 'Person'
        '@id': 'https://epialert.weiqi.kids/about#person'
        name: 'EpiAlert AI ç·¨è¼¯'
        url: 'https://epialert.weiqi.kids/about'
        description: 'AI é©…å‹•çš„ç–«æƒ…è³‡è¨Šå½™æ•´ç³»çµ±ï¼Œè‡ªå‹•æ”¶é›†ä¸¦åˆ†æä¾†è‡ª WHOã€CDC ç­‰å®˜æ–¹ä¾†æºçš„å‚³æŸ“ç—…æƒ…å ±'
        worksFor:
          '@id': 'https://epialert.weiqi.kids#organization'
      - '@type': 'Organization'
        '@id': 'https://epialert.weiqi.kids#organization'
        name: 'EpiAlert ç–«æƒ…å¿«è¨Š'
        url: 'https://epialert.weiqi.kids'
        logo:
          '@type': 'ImageObject'
          url: 'https://epialert.weiqi.kids/assets/images/logo.png'
          width: 600
          height: 60
        description: 'å…¨çƒå‚³æŸ“ç—…æƒ…å ±è‡ªå‹•æ”¶é›†èˆ‡åˆ†æç³»çµ±'
      - '@type': 'BreadcrumbList'
        itemListElement:
          - '@type': 'ListItem'
            position: 1
            name: 'é¦–é '
            item: 'https://epialert.weiqi.kids'
          - '@type': 'ListItem'
            position: 2
            name: 'é€±å ±'
            item: 'https://epialert.weiqi.kids/Narrator/weekly_digest/'
          - '@type': 'ListItem'
            position: 3
            name: 'å‚³æŸ“ç—…å¨è„…é€±å ± 2026-W09'
            item: 'https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W09'
  ymyl:
    lastReviewed: '2026-02-26T23:00:00+08:00'
    reviewedBy: 'EpiAlert AI ç·¨è¼¯'
    medicalDisclaimer: 'æœ¬å ±å‘Šç”±è‡ªå‹•åŒ–ç³»çµ±ç”Ÿæˆï¼Œåƒ…ä¾›åƒè€ƒç”¨é€”ã€‚å ±å‘Šå…§å®¹åŸºæ–¼å…¬é–‹è³‡è¨Šä¾†æºï¼Œä¸æ§‹æˆé†«ç™‚å»ºè­°ã€å®˜æ–¹æ”¿ç­–æˆ–å°ˆæ¥­è¨ºæ–·ã€‚ä½¿ç”¨è€…æ‡‰è‡ªè¡Œé©—è­‰è³‡è¨Šä¸¦è«®è©¢å°ˆæ¥­äººå£«ã€‚'
---

# å‚³æŸ“ç—…å¨è„…é€±å ± 2026-W09

<div class="ymyl-disclaimer">
æœ¬ç«™å…§å®¹ç”± AI è‡ªå‹•å½™æ•´è‡ª WHOã€CDC ç­‰å®˜æ–¹ä¾†æºï¼Œåƒ…ä¾›åƒè€ƒï¼Œä¸æ§‹æˆé†«ç™‚å»ºè­°ã€‚å¦‚æœ‰å¥åº·ç–‘æ…®ï¼Œè«‹è«®è©¢å°ˆæ¥­é†«ç™‚äººå“¡ã€‚
</div>

> **å…è²¬è²æ˜**
>
> æœ¬å ±å‘Šç”±è‡ªå‹•åŒ–ç³»çµ±ç”Ÿæˆï¼Œåƒ…ä¾›åƒè€ƒç”¨é€”ã€‚å ±å‘Šå…§å®¹åŸºæ–¼å…¬é–‹è³‡è¨Šä¾†æºï¼Œ
> ä¸æ§‹æˆé†«ç™‚å»ºè­°ã€å®˜æ–¹æ”¿ç­–æˆ–å°ˆæ¥­è¨ºæ–·ã€‚ä½¿ç”¨è€…æ‡‰è‡ªè¡Œé©—è­‰è³‡è¨Šä¸¦è«®è©¢
> å°ˆæ¥­äººå£«ã€‚

---

## æœ¬é€±é‡é»
{: .speakable-content}

<div class="key-takeaway" markdown="1">

- **ç™»é©ç†±å¢ƒå¤–ç§»å…¥é¢¨éšªä¸Šå‡**ï¼šå¹´å‡çµæŸåŠ 228 é€£å‡äººæµå¢åŠ ï¼Œå°ç£ä»Šå¹´æˆªè‡³ 2/25 ç´¯è¨ˆ 19 ä¾‹å¢ƒå¤–ç§»å…¥ç—…ä¾‹ï¼Œä»¥å°å°¼ 6 ä¾‹æœ€å¤šã€‚ç–¾ç®¡ç½²å‘¼ç±²é†«å¸«å°å…·æ±å—äºã€å—äºæ—…éŠå²çš„ç™¼ç‡’ç—…æ‚£æé«˜è­¦è¦ºï¼ŒåŠæ™‚ä½¿ç”¨ NS1 å¿«é€Ÿè¨ºæ–·è©¦åŠ‘ã€‚(tw_cdc_alerts) **[2/26 æ›´æ–°]**

- **è«¾ç¾…ç—…æ¯’ç–«æƒ…é”è¿‘äº”å¹´é«˜å³°**ï¼šå°ç£æ˜¥ç¯€æœŸé–“è…¹ç€‰ç¾¤èšæ¡ˆä»¶ä»¥è«¾ç¾…ç—…æ¯’ç‚ºä¸»ï¼ˆå  83.8%ï¼‰ï¼Œè¿‘å››é€±å…± 122 èµ·è…¹ç€‰ç¾¤èšé€šå ±ã€‚éŸ“åœ‹ã€æ—¥æœ¬åŠè‹±åœ‹è«¾ç¾…ç—…æ¯’æ„ŸæŸ“ç–«æƒ…ç‚ºè¿‘ 5 å¹´æœ€é«˜ï¼Œç¾©å¤§åˆ©å†¬å­£å¥§é‹äº¦å‚³å‡ºç¾¤èšç–«æƒ…ã€‚(tw_cdc_alerts)

- **è‹±åœ‹å‘¼ç±²å¸¶ç‹€ç–±ç–¹ç–«è‹—æ¥ç¨®**ï¼šUKHSA æŒ‡å‡ºç¬¦åˆå…è²»å¸¶ç‹€ç–±ç–¹ç–«è‹—æ¥ç¨®è³‡æ ¼çš„æ°‘çœ¾ä¸­ï¼Œåªæœ‰ä¸åˆ° 50% å·²æ¥ç¨®ï¼Œå‘¼ç±²æ•¸ç™¾è¬ç¬¦åˆæ¢ä»¶è€…å„˜é€Ÿæ¥ç¨®ã€‚åŒæ™‚ç™¼å¸ƒ Shingrix ç–«è‹—è©•ä¼°å ±å‘Šã€‚(uk_ukhsa_updates) **[2/26 æ›´æ–°]**

- **è‹±åœ‹ç™¼å¸ƒ 2026-2027 å¹´æµæ„Ÿè¨ˆç•«**ï¼šUKHSA ç™¼å¸ƒå¹´åº¦æµæ„Ÿä¿¡å‡½ï¼Œè©³è¿°åœ‹å®¶æµæ„Ÿå…ç–«æ¥ç¨®è¨ˆç•«çš„å¯¦æ–½å®‰æ’ï¼Œæ˜ç¢º 65 æ­²ä»¥ä¸Šã€å­•å©¦ã€é†«è­·äººå“¡ã€2-17 æ­²å…’ç«¥ç­‰ç¬¦åˆå…è²»æ¥ç¨®è³‡æ ¼çš„æ—ç¾¤ã€‚(uk_ukhsa_updates) **[2/26 æ›´æ–°]**

- **å°ç£å…¬è²»ç–«è‹—æ¥ç¨®è™•ç½®è²»èª¿æ•´**ï¼šè‡ª 3/1 èµ·ï¼Œ6 æ­²ä»¥ä¸‹å¹¼å…’æ¯åŠ‘æ¬¡èª¿å‡è‡³ 200 å…ƒï¼Œå…¶é¤˜æ¥ç¨®å°è±¡èª¿è‡³ 150 å…ƒã€‚æ ¸ä»˜æ–¹å¼æ”¹ç”±ç–¾ç®¡ç½²æŒ‰æœˆä¾ NIIS ç³»çµ±è³‡æ–™æ ¸ç®—ã€‚(tw_cdc_alerts) **[2/26 æ›´æ–°]**

- **è‹±åœ‹æµæ„Ÿç–«è‹—æ¥ç¨®ç‡ç›£æ¸¬æ›´æ–°**ï¼šUKHSA ç™¼å¸ƒ 2025-2026 å¹´åº¦é†«è­·äººå“¡åŠå­¸é½¡å…’ç«¥æµæ„Ÿç–«è‹—æ¥ç¨®ç‡æ¯æœˆæ•¸æ“šï¼Œç‚ºè©•ä¼°æµæ„Ÿå…ç–«è¨ˆç•«æˆæ•ˆæä¾›é—œéµæŒ‡æ¨™ã€‚(uk_ukhsa_updates) **[2/26 æ›´æ–°]**

- **å°ç£å…¬è²»æµæ„ŸæŠ—ç—…æ¯’è—¥åŠ‘æ”¿ç­–èª¿æ•´**ï¼šæ“´å¤§ä½¿ç”¨æ¢ä»¶æªæ–½å°‡æ–¼ 2/28 æˆªæ­¢ï¼Œ3/1 èµ·æ¢å¾©æ­£å¸¸ç”¨è—¥è³‡æ ¼ï¼ˆ10 é …é©æ‡‰æ¢ä»¶ï¼‰ã€‚æ–°å† ç–«è‹—æ“´å¤§å…¨æ°‘æ¥ç¨®å»¶é•·è‡³ 4/30ã€‚å…¬è²»æµæ„Ÿç–«è‹—åƒ…é¤˜ç´„ 8 è¬åŠ‘ã€‚(tw_cdc_alerts)

- **éº»ç–¹ã€ç™¾æ—¥å’³æŒçºŒè¿½è¹¤**ï¼šå°ç£é¦–ä¾‹éº»ç–¹å¢ƒå¤–ç§»å…¥ç—…ä¾‹æ¥è§¸è€…ç›£æ¸¬å·²æ–¼ 2/28 çµæŸï¼Œé¦–ä¾‹ç™¾æ—¥å’³ç—…ä¾‹å®¶åº­æ¥è§¸è€…ç›£æ¸¬è‡³ 3/4ã€‚(tw_cdc_alerts)

</div>

---

## è¡Œå‹•å»ºè­°
{: .actionable-steps }

æ ¹æ“šæœ¬é€±ç–«æƒ…å‹•æ…‹ï¼Œå»ºè­°æ¡å–ä»¥ä¸‹è¡Œå‹•ï¼š

### ç™»é©ç†±é˜²æ²»å»ºè­°ï¼ˆå¢ƒå¤–ç§»å…¥é¢¨éšªä¸Šå‡ï¼‰

| å°è±¡ | å»ºè­°æªæ–½ | å„ªå…ˆç´š |
|------|----------|--------|
| æ±å—äº/å—äºè¿”åœ‹æ—…å®¢ | è¿”åœ‹å¾Œ 2 é€±å…§å‡ºç¾ç™¼ç‡’ã€è‚Œè‚‰ç—›ã€å‡ºç–¹æ‡‰å°±é†«ä¸¦å‘ŠçŸ¥æ—…éŠå² | ğŸ”´ é«˜ |
| è‡¨åºŠé†«å¸« | å°å…·æ—…éŠå²ç–‘ä¼¼ç—…ä¾‹åŠæ™‚ä½¿ç”¨ NS1 å¿«é€Ÿè¨ºæ–·è©¦åŠ‘ | ğŸ”´ é«˜ |
| å‡ºåœ‹æ°‘çœ¾ | å‰å¾€ç™»é©ç†±æµè¡Œå€æ‡‰åšå¥½é˜²èšŠæªæ–½ | ğŸŸ¡ ä¸­ |

### é£Ÿå“è¡›ç”Ÿå»ºè­°ï¼ˆè«¾ç¾…ç—…æ¯’é˜²æ²»ï¼‰

| å ´æ‰€ | å»ºè­°æªæ–½ | å„ªå…ˆç´š |
|------|----------|--------|
| é¤é£²æ—…å®¿æ¥­ | è½å¯¦å»šæˆ¿ç’°å¢ƒæ¶ˆæ¯’èˆ‡æ¸…æ½”ï¼Œå“¡å·¥å¥åº·ç®¡ç† | ğŸ”´ é«˜ |
| å®¶åº­ | ç”Ÿç†Ÿé£Ÿåˆ†é–‹è™•ç†ï¼Œé£Ÿç‰©æ¾ˆåº•ç…®ç†Ÿ | ğŸ”´ é«˜ |
| å€‹äºº | å¦‚å»å¾Œã€é€²é£Ÿå‰ä»¥è‚¥çš‚æ­£ç¢ºæ´—æ‰‹ | ğŸ”´ é«˜ |

### å­¸æ ¡é–‹å­¸è¡›ç”Ÿæªæ–½ï¼ˆè…¸ç—…æ¯’é˜²æ²»ï¼‰

| å°è±¡ | å»ºè­°æªæ–½ | å„ªå…ˆç´š |
|------|----------|--------|
| æ•™æ‰˜è‚²æ©Ÿæ§‹ | åŠ å¼·ç’°å¢ƒé€šé¢¨ã€æ¸…æ½”èˆ‡æ¶ˆæ¯’ | ğŸŸ¡ ä¸­ |
| å®¶é•· | æ•™å°å­¸ç«¥æ­£ç¢ºæ´—æ‰‹ï¼ˆæ¿•æ“æ²–æ§æ“¦ï¼‰ | ğŸŸ¡ ä¸­ |
| å¹¼ç«¥ | æ„ŸæŸ“è…¸ç—…æ¯’æ‡‰åœ¨å®¶ä¼‘æ¯ï¼Œé¿å…ç¾¤èš | ğŸ”´ é«˜ |

### æµæ„Ÿé˜²æ²»å»ºè­°

| å°è±¡ | å»ºè­° | æˆªæ­¢æ—¥æœŸ |
|------|------|----------|
| 65 æ­²ä»¥ä¸Šé•·è€…ã€æ…¢æ€§ç—…æ‚£ | æŠŠæ¡å…¬è²»ç–«è‹—æœ€å¾Œæ©Ÿæœƒï¼ˆåƒ…é¤˜ç´„ 8 è¬åŠ‘ï¼‰ | ç”¨å®Œç‚ºæ­¢ |
| ç¬¦åˆå…¬è²»è—¥åŠ‘ç”¨è—¥æ¢ä»¶è€… | 3/1 èµ·æ¢å¾©æ­£å¸¸ç”¨è—¥è³‡æ ¼ | 2/28 å‰ä»é©ç”¨æ“´å¤§æ¢ä»¶ |
| æ»¿ 6 å€‹æœˆä»¥ä¸Šæ°‘çœ¾ | æ–°å† ç–«è‹—æ“´å¤§å…¨æ°‘æ¥ç¨®å»¶é•· | 2026/4/30 |

---

## èˆ‡ä¸Šé€±æ¯”è¼ƒ

### æ–°å¢å¨è„…

- **ç™»é©ç†±å¢ƒå¤–ç§»å…¥é¢¨éšªä¸Šå‡ï¼ˆå°ç£ï¼‰**ï¼šå¹´å‡çµæŸåŠ 228 é€£å‡äººæµå¢åŠ ï¼Œä»Šå¹´æˆªè‡³ 2/25 ç´¯è¨ˆ 19 ä¾‹å¢ƒå¤–ç§»å…¥ç—…ä¾‹ï¼Œä»¥å°å°¼ 6 ä¾‹æœ€å¤šï¼Œå…¶æ¬¡ç‚ºè²å¾‹è³“ã€è¶Šå—ã€æ³°åœ‹ã€é¦¬ä¾†è¥¿äºç­‰ã€‚ç–¾ç®¡ç½²ç™¼å¸ƒç¬¬ 600 è™Ÿè‡´é†«ç•Œé€šå‡½ï¼Œå‘¼ç±²é†«å¸«å°å…·æ±å—äºã€å—äºæ—…éŠå²çš„ç™¼ç‡’ç—…æ‚£æé«˜è­¦è¦ºã€‚**[2/26 æ›´æ–°]**

- **è‹±åœ‹å¸¶ç‹€ç–±ç–¹ç–«è‹—æ¥ç¨®å‘¼ç±²ï¼ˆè‹±åœ‹ï¼‰**ï¼šUKHSA æŒ‡å‡ºç¬¦åˆå…è²»å¸¶ç‹€ç–±ç–¹ç–«è‹—æ¥ç¨®è³‡æ ¼çš„æ°‘çœ¾ä¸­ï¼Œåªæœ‰ä¸åˆ° 50% å·²æ¥ç¨®ï¼Œå‘¼ç±²æ•¸ç™¾è¬ç¬¦åˆæ¢ä»¶è€…å„˜é€Ÿè¯ç¹« GP æˆ–è—¥æˆ¿é ç´„æ¥ç¨®ï¼Œä»¥é™ä½å¸¶ç‹€ç–±ç–¹åŠå¸¶ç‹€ç–±ç–¹å¾Œç¥ç¶“ç—›é¢¨éšªã€‚**[2/26 æ›´æ–°]**

- **è‹±åœ‹ 2026-2027 å¹´æµæ„Ÿå…ç–«è¨ˆç•«ï¼ˆè‹±åœ‹ï¼‰**ï¼šUKHSA ç™¼å¸ƒå¹´åº¦æµæ„Ÿä¿¡å‡½ï¼Œè©³è¿°åœ‹å®¶æµæ„Ÿå…ç–«æ¥ç¨®è¨ˆç•«çš„å¯¦æ–½å®‰æ’ï¼Œæ¶µè“‹ 65 æ­²ä»¥ä¸Šã€å­•å©¦ã€é†«è­·äººå“¡ã€2-17 æ­²å…’ç«¥ã€æ…¢æ€§ç—…æ‚£ç­‰ç¬¦åˆå…è²»æ¥ç¨®è³‡æ ¼çš„æ—ç¾¤ã€‚**[2/26 æ›´æ–°]**

- **Shingrix å¸¶ç‹€ç–±ç–¹ç–«è‹—è©•ä¼°å ±å‘Šï¼ˆè‹±åœ‹ï¼‰**ï¼šUKHSA ç™¼å¸ƒé‡å°è‹±æ ¼è˜­åœ°å€ Shingrix å¸¶ç‹€ç–±ç–¹ç–«è‹—æ¥ç¨®è¨ˆåŠƒçš„è©•ä¼°å ±å‘Šï¼Œæ¶µè“‹ 2023/24 å’Œ 2024/25 å­¸å¹´åº¦çš„å¯¦æ–½æˆæ•ˆã€‚**[2/26 æ›´æ–°]**

- **è«¾ç¾…ç—…æ¯’å…¨çƒé«˜å³°ï¼ˆå¤šåœ‹ï¼‰**ï¼šå°ç£ã€éŸ“åœ‹ã€æ—¥æœ¬ã€è‹±åœ‹è«¾ç¾…ç—…æ¯’ç–«æƒ…å‡é”è¿‘ 5 å¹´æœ€é«˜ã€‚å°ç£è¿‘å››é€± 122 èµ·è…¹ç€‰ç¾¤èšé€šå ±ï¼Œ83.8% æª¢å‡ºè«¾ç¾…ç—…æ¯’ã€‚ç¾©å¤§åˆ©å†¬å­£å¥§é‹å‚³å‡ºç¾¤èšç–«æƒ…ã€‚

### å‡ç´šè­¦ç¤º

- **å°ç£å…¬è²»ç–«è‹—æ¥ç¨®è™•ç½®è²»èª¿å‡**ï¼ˆ3/1 ç”Ÿæ•ˆï¼‰ï¼š
  - 6 æ­²ä»¥ä¸‹å¹¼å…’æ¯åŠ‘æ¬¡ï¼š200 å…ƒï¼ˆåŸ 100 å…ƒï¼‰
  - å…¶é¤˜æ¥ç¨®å°è±¡æ¯åŠ‘æ¬¡ï¼š150 å…ƒï¼ˆåŸ 100 å…ƒï¼‰
  - æ ¸ä»˜æ–¹å¼æ”¹ç”±ç–¾ç®¡ç½²æŒ‰æœˆä¾ NIIS ç³»çµ±è³‡æ–™æ ¸ç®— **[2/26 æ›´æ–°]**

- **å°ç£æµæ„Ÿæ”¿ç­–èª¿æ•´**ï¼š
  - å…¬è²»æµæ„ŸæŠ—ç—…æ¯’è—¥åŠ‘æ“´å¤§ä½¿ç”¨æ¢ä»¶ 2/28 æˆªæ­¢
  - 3/1 èµ·æ¢å¾©æ­£å¸¸ 10 é …é©æ‡‰æ¢ä»¶
  - æ–°å† ç–«è‹—æ“´å¤§å…¨æ°‘æ¥ç¨®å»¶é•·è‡³ 4/30
  - å…¬è²»æµæ„Ÿç–«è‹—åƒ…é¤˜ç´„ 8 è¬åŠ‘

- **è‹±åœ‹æµæ„Ÿç–«è‹—æ¥ç¨®ç‡ç›£æ¸¬**ï¼š
  - UKHSA ç™¼å¸ƒ 2025-2026 å¹´åº¦é†«è­·äººå“¡æµæ„Ÿç–«è‹—æ¥ç¨®ç‡æ¯æœˆæ•¸æ“š
  - UKHSA ç™¼å¸ƒ 2025-2026 å¹´åº¦å­¸é½¡å…’ç«¥æµæ„Ÿç–«è‹—æ¥ç¨®ç‡æ¯æœˆæ•¸æ“š **[2/26 æ›´æ–°]**

### æŒçºŒé—œæ³¨

- **éº»ç–¹ï¼ˆMeaslesï¼‰**ï¼šå°ç£é¦–ä¾‹å¢ƒå¤–ç§»å…¥ç—…ä¾‹æ¥è§¸è€…ç›£æ¸¬å·²æ–¼ 2/28 çµæŸã€‚å…¨çƒç–«æƒ…ä»ç„¶åš´å³»ã€‚

- **ç™¾æ—¥å’³ï¼ˆPertussisï¼‰**ï¼šå°ç£é¦–ä¾‹ç™¾æ—¥å’³ç—…ä¾‹å®¶åº­æ¥è§¸è€…ç›£æ¸¬è‡³ 3/4ã€‚å…¨çƒç–«æƒ…åš´å³»ï¼Œæ—¥æœ¬å»å¹´é€¾ 8 è¬ä¾‹ã€‚

- **çŒ´ç—˜ï¼ˆMpoxï¼‰**ï¼šUKHSA æŒçºŒæ›´æ–° clade Ib åŠ clade IIb æµè¡Œç—…å­¸æ¦‚æ³ï¼Œç¶­æŒç›£æ¸¬ã€‚

- **æµæ„Ÿï¼ˆInfluenzaï¼‰**ï¼šå°ç£æµæ„Ÿç–«æƒ…å‘ˆä¸‹é™è¶¨å‹¢ï¼Œæ˜¥ç¯€å‰å¾Œå‡æœªé€²å…¥æµè¡ŒæœŸã€‚éŸ“åœ‹ã€æ—¥æœ¬æµæ„Ÿç–«æƒ…è™•é«˜é»ã€‚

- **ç«‹ç™¾ç—…æ¯’ç—…ï¼ˆNipah Virus Diseaseï¼‰**ï¼šå°åº¦è¥¿å­ŸåŠ æ‹‰é‚¦ç–«æƒ…æŒçºŒç›£æ¸¬ã€‚å°ç£é è¨ˆ 3 æœˆä¸­åˆ—ç‚ºç¬¬äº”é¡æ³•å®šå‚³æŸ“ç—…ã€‚

- **æŠ—å¾®ç”Ÿç‰©æŠ—è—¥æ€§ï¼ˆAMRï¼‰**ï¼šECDC ä¸Šé€±å»ºè­°æ–°å»ºæ­ç›Ÿåƒè€ƒå¯¦é©—å®¤ï¼Œæœ¬é€± UKHSA ç™¼å¸ƒ ESPAUR å¹´åº¦å ±å‘ŠåŠè‰±é›£æ¢­èŒç›£æ¸¬å ±å‘Šã€‚

### å·²è§£é™¤ / é™ç´š

- **ECDC æ­ç›Ÿåƒè€ƒå¯¦é©—å®¤ææ¡ˆ**ï¼šä¸Šé€±æ–°å¢é …ç›®ï¼Œæœ¬é€±å·²ç´å…¥å¸¸æ…‹è¿½è¹¤ã€‚

- **éº»ç–¹æ¥è§¸è€…ç›£æ¸¬ï¼ˆå°ç£ï¼‰**ï¼šé¦–ä¾‹å¢ƒå¤–ç§»å…¥ç—…ä¾‹çš„ 400 åæ¥è§¸è€…ç›£æ¸¬æœŸå·²æ–¼ 2/28 çµæŸï¼Œæœªæœ‰æ–°å¢ç—…ä¾‹ã€‚

---

## è¶¨å‹¢åœ–è¡¨
{: .speakable-content }

<p class="key-answer" data-question="æœ¬é€±ç–«æƒ…è¶¨å‹¢å¦‚ä½•">æœ¬é€±è«¾ç¾…ç—…æ¯’ç‚ºä¸»è¦å¨è„…ï¼Œå°ç£åŠå¤šåœ‹å‡é”è¿‘äº”å¹´é«˜å³°ï¼›æµæ„Ÿç–«æƒ…ä¸‹é™ï¼Œé–‹å­¸å¾Œéœ€é—œæ³¨è…¸ç—…æ¯’å‚³æ’­é¢¨éšªã€‚</p>

### éå» 8 é€±ç–«æƒ…äº‹ä»¶æ•¸é‡

<canvas id="weeklyTrendChart" width="400" height="200" aria-label="éå» 8 é€±ç–«æƒ…äº‹ä»¶æ•¸é‡è¶¨å‹¢åœ–" role="img"></canvas>

<noscript>
<p>åœ–è¡¨éœ€è¦ JavaScript æ”¯æ´ã€‚ä»¥ä¸‹ç‚ºæ–‡å­—ç‰ˆæ•¸æ“šï¼š</p>
<ul>
<li>W02: 42 ä»¶</li>
<li>W03: 38 ä»¶</li>
<li>W04: 45 ä»¶</li>
<li>W05: 52 ä»¶</li>
<li>W06: 48 ä»¶</li>
<li>W07: 44 ä»¶</li>
<li>W08: 42 ä»¶</li>
<li>W09: 46 ä»¶</li>
</ul>
</noscript>

### æœ¬é€±ç–¾ç—…åˆ†å¸ƒ

<canvas id="diseaseDistChart" width="400" height="200" aria-label="æœ¬é€±ç–¾ç—…åˆ†å¸ƒåœ“é¤…åœ–" role="img"></canvas>

<noscript>
<p>åœ–è¡¨éœ€è¦ JavaScript æ”¯æ´ã€‚ä»¥ä¸‹ç‚ºæ–‡å­—ç‰ˆæ•¸æ“šï¼š</p>
<ul>
<li>è…¸èƒƒé“ç–¾ç—…ï¼ˆè«¾ç¾…ç—…æ¯’ï¼‰: 30%</li>
<li>å‘¼å¸é“ç–¾ç—…: 25%</li>
<li>ç–«è‹—å¯é é˜²ç–¾ç—…: 20%</li>
<li>é†«ç™‚æ©Ÿæ§‹æ„ŸæŸ“: 15%</li>
<li>å…¶ä»–: 10%</li>
</ul>
</noscript>

<script src="https://cdn.jsdelivr.net/npm/chart.js@4.4.1/dist/chart.umd.min.js"></script>
<script>
document.addEventListener('DOMContentLoaded', function() {
  // Weekly trend chart
  var trendCtx = document.getElementById('weeklyTrendChart');
  if (trendCtx) {
    new Chart(trendCtx, {
      type: 'line',
      data: {
        labels: ['W02', 'W03', 'W04', 'W05', 'W06', 'W07', 'W08', 'W09'],
        datasets: [{
          label: 'ç–«æƒ…äº‹ä»¶æ•¸',
          data: [42, 38, 45, 52, 48, 44, 42, 46],
          borderColor: '#7253ed',
          backgroundColor: 'rgba(114, 83, 237, 0.1)',
          fill: true,
          tension: 0.3
        }]
      },
      options: {
        responsive: true,
        plugins: {
          legend: { display: false },
          title: { display: false }
        },
        scales: {
          y: { beginAtZero: true, title: { display: true, text: 'äº‹ä»¶æ•¸' } },
          x: { title: { display: true, text: '2026 å¹´é€±æ¬¡' } }
        }
      }
    });
  }

  // Disease distribution chart
  var distCtx = document.getElementById('diseaseDistChart');
  if (distCtx) {
    new Chart(distCtx, {
      type: 'doughnut',
      data: {
        labels: ['è…¸èƒƒé“ç–¾ç—…', 'å‘¼å¸é“ç–¾ç—…', 'ç–«è‹—å¯é é˜²ç–¾ç—…', 'é†«ç™‚æ©Ÿæ§‹æ„ŸæŸ“', 'å…¶ä»–'],
        datasets: [{
          data: [30, 25, 20, 15, 10],
          backgroundColor: ['#f0883e', '#7253ed', '#2ea44f', '#0366d6', '#6a737d']
        }]
      },
      options: {
        responsive: true,
        plugins: {
          legend: { position: 'right' }
        }
      }
    });
  }
});
</script>

---

## å…¨çƒç–«æƒ…æ¦‚è¦½

### æ–°èˆˆå¨è„…

#### ç™»é©ç†±å¢ƒå¤–ç§»å…¥é¢¨éšª â€” å°ç£
{: #dengue-importation}

<p class="key-answer" data-question="å°ç£ç™»é©ç†±å¢ƒå¤–ç§»å…¥æƒ…æ³å¦‚ä½•">2026 å¹´æˆªè‡³ 2/25 ç´¯è¨ˆ 19 ä¾‹å¢ƒå¤–ç§»å…¥ç—…ä¾‹ï¼Œä»¥å°å°¼ 6 ä¾‹æœ€å¤šï¼Œå…¶æ¬¡ç‚ºè²å¾‹è³“ã€è¶Šå—ã€æ³°åœ‹ã€é¦¬ä¾†è¥¿äºã€æ–¯é‡Œè˜­å¡ã€å°åº¦åŠé¦¬çˆ¾åœ°å¤«ã€‚</p>

ç–¾ç®¡ç½² 2 æœˆ 26 æ—¥ç™¼å¸ƒç¬¬ 600 è™Ÿè‡´é†«ç•Œé€šå‡½ï¼Œæé†’ç™»é©ç†±å¢ƒå¤–ç§»å…¥é¢¨éšªä¸Šå‡ï¼š

**ç–«æƒ…ç¾æ³**ï¼š

| æŒ‡æ¨™ | æ•¸æ“š |
|------|------|
| 2026 å¹´å¢ƒå¤–ç§»å…¥ç—…ä¾‹ | 19 ä¾‹ï¼ˆæˆªè‡³ 2/25ï¼‰ |
| ä¸»è¦ç§»å…¥åœ‹å®¶ | å°å°¼ï¼ˆ6 ä¾‹ï¼‰æœ€å¤š |
| å…¶ä»–ç§»å…¥åœ‹å®¶ | è²å¾‹è³“ã€è¶Šå—ã€æ³°åœ‹ã€é¦¬ä¾†è¥¿äºã€æ–¯é‡Œè˜­å¡ã€å°åº¦ã€é¦¬çˆ¾åœ°å¤« |
| æœ€æ–°å€‹æ¡ˆ | åŒ—éƒ¨ 50 å¤šæ­²ç”·æ€§ï¼Œé¦¬çˆ¾åœ°å¤«æ—…éŠå² |

**è‡¨åºŠç—‡ç‹€**ï¼š
- ç™¼ç‡’ã€é ­ç—›ã€å¾Œçœ¼çª©ç—›
- è‚Œè‚‰ç—›ã€é—œç¯€ç—›ã€éª¨é ­ç—›
- å‡ºç–¹
- éƒ¨åˆ†å€‹æ¡ˆæœ‰è…¹ç€‰ç—‡ç‹€

**é†«å¸«æ³¨æ„äº‹é …**ï¼š

<ol class="actionable-steps">
<li>å°å…·æ±å—äºã€å—äºåŠå—ç¾æ´²æ—…éŠå²çš„ç™¼ç‡’ç—…æ‚£æé«˜è­¦è¦º</li>
<li>é©æ™‚ä½¿ç”¨ç™»é©ç†± NS1 å¿«é€Ÿè¨ºæ–·è©¦åŠ‘</li>
<li>è©³ç´°è©¢å• TOCCï¼ˆæ—…éŠå²ã€è·æ¥­åˆ¥ã€æ¥è§¸å²ã€æ˜¯å¦ç¾¤èšï¼‰</li>
<li>ç™»é©ç†±å€‹æ¡ˆç™¼ç—…å‰ 1 å¤©è‡³ç™¼ç—…å¾Œ 5 å¤©ç‚ºç—…æ¯’è¡€ç—‡æœŸï¼Œå…·å‚³æŸ“æ€§</li>
</ol>

ä¾†æºï¼štw_cdc_alerts/medical_advisory/2026-02-26-dengue-fever-importation-risk-alert.md **[2/26 æ›´æ–°]**

##### æ­·å²åƒè€ƒ [èªæ„æœå°‹]

| æ—¥æœŸ | æ¨™é¡Œ | ä¾†æº | ç›¸é—œåˆ†æ•¸ |
|------|------|------|----------|
| 2025-04-22 | Taiwan CDC hosts APEC Conference on Dengue Prevention and Control | Taiwan CDC | 0.54 |
| 2020-02-13 | Travel-Associated and Locally Acquired Dengue Cases - US, 2010-2017 | US CDC MMWR | 0.54 |
| 2024-10-24 | First Locally Acquired Dengue - Pasadena, California | US CDC MMWR | 0.54 |

#### è«¾ç¾…ç—…æ¯’ç–«æƒ… â€” å…¨çƒ
{: #norovirus-outbreak}

<p class="key-answer" data-question="è«¾ç¾…ç—…æ¯’ç–«æƒ…ç¾æ³å¦‚ä½•">å°ç£ã€éŸ“åœ‹ã€æ—¥æœ¬ã€è‹±åœ‹è«¾ç¾…ç—…æ¯’æ„ŸæŸ“ç–«æƒ…å‡é”è¿‘ 5 å¹´æœ€é«˜ï¼Œç¾©å¤§åˆ©å†¬å­£å¥§é‹äº¦å‚³å‡ºç¾¤èšç–«æƒ…ã€‚</p>

ç–¾ç®¡ç½² 2 æœˆ 24 æ—¥æŒ‡å‡ºï¼Œæ˜¥ç¯€æœŸé–“è…¹ç€‰ç¾¤èšæ¡ˆä»¶ä»¥è«¾ç¾…ç—…æ¯’ç‚ºä¸»ï¼š

**å°ç£ç–«æƒ…**ï¼š

| æŒ‡æ¨™ | æ•¸æ“š |
|------|------|
| ç¬¬ 5 é€±è…¹ç€‰é–€æ€¥è¨º | 142,814 äººæ¬¡ |
| ç¬¬ 6 é€±è…¹ç€‰é–€æ€¥è¨º | 171,756 äººæ¬¡ï¼ˆä¸Šå‡è¶¨å‹¢ï¼‰ |
| ç¬¬ 7 é€±è…¹ç€‰é–€æ€¥è¨º | 80,308 äººæ¬¡ï¼ˆæ˜¥ç¯€é–€è¨ºä¼‘è¨ºå½±éŸ¿ï¼‰ |
| è¿‘å››é€±ç¾¤èšé€šå ± | 122 èµ· |
| æª¢å‡ºè«¾ç¾…ç—…æ¯’ | 31 ä»¶ï¼ˆå  83.8%ï¼‰ |
| ç™¼ç”Ÿå ´æ‰€ | é¤é£²æ—…å®¿æ¥­ç‚ºä¸» |

**åœ‹éš›ç–«æƒ…**ï¼š

| åœ‹å®¶/åœ°å€ | ç‹€æ³ |
|-----------|------|
| éŸ“åœ‹ | è¿‘ 5 å¹´æœ€é«˜ |
| æ—¥æœ¬ | è¿‘ 5 å¹´æœ€é«˜ |
| è‹±åœ‹ | è¿‘ 5 å¹´æœ€é«˜ |
| ä¸­åœ‹ã€é¦™æ¸¯ | è…¹ç€‰ç—…ä¾‹å¢åŠ  |
| ç¾©å¤§åˆ© | å†¬å­£å¥§é‹å‚³å‡ºç¾¤èšç–«æƒ… |

**é é˜²æªæ–½**ï¼š

<ol class="actionable-steps">
<li>å¦‚å»å¾Œã€é€²é£Ÿå‰ä»¥è‚¥çš‚æ­£ç¢ºæ´—æ‰‹</li>
<li>ç”Ÿç†Ÿé£Ÿåˆ†é–‹è™•ç†ï¼Œé£Ÿç‰©æ¾ˆåº•ç…®ç†Ÿ</li>
<li>é¿å…ç”Ÿé£Ÿç”Ÿé£²ï¼ˆå°¤å…¶èšµã€è²é¡ç­‰å¸¶æ®¼æ°´ç”¢ï¼‰</li>
<li>æœ‰è…¹ç€‰ã€å˜”åç—‡ç‹€è€…æ‡‰åœ¨å®¶ä¼‘æ¯è‡³ç—‡ç‹€è§£é™¤ 48 å°æ™‚</li>
<li>ç’°å¢ƒæ¶ˆæ¯’ä½¿ç”¨ç¨€é‡‹æ¼‚ç™½æ°´ï¼ˆ1,000-5,000 ppmï¼‰</li>
</ol>

ä¾†æºï¼štw_cdc_alerts/domestic_outbreak/2026-02-24-norovirus-outbreak-lunar-new-year.md **[æœ¬é€±æ–°å¢]**

##### æ­·å²åƒè€ƒ [èªæ„æœå°‹]

| æ—¥æœŸ | æ¨™é¡Œ | ä¾†æº | ç›¸é—œåˆ†æ•¸ |
|------|------|------|----------|
| 2026-02-05 | National norovirus and rotavirus surveillance reports: 2025 to 2026 season | UKHSA | 0.66 |
| 2022-09-22 | Notes from the Field: Norovirus Outbreaks - 12 States | US CDC MMWR | 0.63 |
| 2026-01-29 | Norovirus cases climb 18.3% in 2 weeks (UKHSA Winter Bulletin) | UKHSA | 0.62 |

#### è…¸ç—…æ¯’é–‹å­¸è­¦ç¤º â€” å°ç£
{: #enterovirus-schools}

<p class="key-answer" data-question="é–‹å­¸å¾Œè…¸ç—…æ¯’å¦‚ä½•é é˜²">æ•™å°å­¸ç«¥ä»¥è‚¥çš‚æ­£ç¢ºæ´—æ‰‹ï¼ˆæ¿•æ“æ²–æ§æ“¦äº”æ­¥é©Ÿï¼‰ï¼Œæ³¨æ„ç’°å¢ƒé€šé¢¨ã€æ¸…æ½”èˆ‡æ¶ˆæ¯’ï¼Œæ„ŸæŸ“è…¸ç—…æ¯’æ‡‰åœ¨å®¶ä¼‘æ¯é¿å…ç¾¤èšã€‚</p>

ç–¾ç®¡ç½² 2 æœˆ 24 æ—¥ç™¼å¸ƒé–‹å­¸è…¸ç—…æ¯’é é˜²è¡›æ•™ï¼š

**å°ç£ç–«æƒ…**ï¼š

| æŒ‡æ¨™ | æ•¸æ“š |
|------|------|
| ç¬¬ 7 é€±é–€æ€¥è¨ºå°±è¨º | 1,856 äººæ¬¡ï¼ˆè¼ƒå‰é€±ä¸‹é™ 64.7%ï¼‰ |
| ä»Šå¹´é‡ç—‡ç¢ºå®šç—…ä¾‹ | 0 ä¾‹ |
| ç¤¾å€ä¸»è¦ç—…æ¯’å‹åˆ¥ | å…‹æ²™å¥‡ A6 å‹ç‚ºå¤šï¼Œå…¶æ¬¡ç‚º A4 å‹ã€A16 å‹ |

**é„°è¿‘åœ‹å®¶/åœ°å€**ï¼š

| åœ‹å®¶/åœ°å€ | ç–«æƒ…ç‹€æ³ |
|-----------|----------|
| ä¸­åœ‹ | ç–«æƒ…ä¸‹é™ä½†é«˜æ–¼è¿‘å¹´åŒæœŸ |
| è¶Šå— | éœ€æ³¨æ„ EV71 å‹é‡ç—‡ç—…ä¾‹ |
| æ—¥æœ¬ã€éŸ“åœ‹ã€æ–°åŠ å¡ | ç–«æƒ…ä½é»æˆ–æŒå¹³ |
| é¦™æ¸¯ | ä½é»å‘ˆæ³¢å‹•ä¸Šå‡ |

**è…¸ç—…æ¯’é‡ç—‡å‰å…†ç—…å¾µ**ï¼ˆéœ€ç«‹å³é€å¤§é†«é™¢ï¼‰ï¼š
- å—œç¡ã€æ„è­˜ä¸æ¸…ã€æ´»åŠ›ä¸ä½³
- æ‰‹è…³ç„¡åŠ›
- è‚ŒæŠ½èºï¼ˆç„¡æ•…é©šåš‡æˆ–çªç„¶é–“å…¨èº«è‚Œè‚‰æ”¶ç¸®ï¼‰
- æŒçºŒå˜”å
- å‘¼å¸æ€¥ä¿ƒæˆ–å¿ƒè·³åŠ å¿«

ä¾†æºï¼štw_cdc_alerts/disease_info/2026-02-24-entrovirus-prevention-schools.md **[æœ¬é€±æ–°å¢]**

##### æ­·å²åƒè€ƒ [èªæ„æœå°‹]

| æ—¥æœŸ | æ¨™é¡Œ | ä¾†æº | ç›¸é—œåˆ†æ•¸ |
|------|------|------|----------|
| 2022-10-06 | Increase in Acute Respiratory Illnesses Among Children Including Enterovirus D68 | US CDC MMWR | 0.57 |
| 2026-02-05 | National norovirus and rotavirus surveillance reports | UKHSA | 0.55 |

#### é†«ç™‚æ©Ÿæ§‹æ„ŸæŸ“ç›£æ¸¬å ±å‘Š â€” è‹±åœ‹
{: #hcai-surveillance}

<p class="key-answer" data-question="è‹±åœ‹é†«ç™‚æ©Ÿæ§‹æ„ŸæŸ“ç›£æ¸¬æ¶µè“‹å“ªäº›ç—…åŸé«”">UKHSA ç›£æ¸¬æ¶µè“‹ MRSA/MSSAã€å¤§è…¸æ¡¿èŒã€å…‹é›·ä¼¯æ°èŒã€ç¶ è†¿æ¡¿èŒã€è‰±é›£æ¢­èŒã€éˆçƒèŒã€è…¸çƒèŒç­‰èŒè¡€ç—‡ï¼Œä»¥åŠæ‰‹è¡“éƒ¨ä½æ„ŸæŸ“ã€‚</p>

UKHSA æ–¼ 2 æœˆ 24 æ—¥ç™¼å¸ƒå¤šé …é†«ç™‚æ©Ÿæ§‹æ„ŸæŸ“ï¼ˆHCAIï¼‰ç›£æ¸¬å ±å‘Šï¼š

**å¹´åº¦ç›£æ¸¬å ±å‘Š**ï¼š

| å ±å‘Š | ç—…åŸé«”/é …ç›® |
|------|-------------|
| MRSA bacteraemia | è€ç”²æ°§è¥¿æ—é‡‘é»ƒè‰²è‘¡è„çƒèŒèŒè¡€ç—‡ |
| MSSA bacteraemia | ç”²æ°§è¥¿æ—æ•æ„Ÿé‡‘é»ƒè‰²è‘¡è„çƒèŒèŒè¡€ç—‡ |
| E. coli bacteraemia | å¤§è…¸æ¡¿èŒèŒè¡€ç—‡ |
| Klebsiella spp. bacteraemia | å…‹é›·ä¼¯æ°èŒå±¬èŒè¡€ç—‡ |
| P. aeruginosa bacteraemia | ç¶ è†¿æ¡¿èŒèŒè¡€ç—‡ |
| C. difficile infection | è‰±é›£æ¢­èŒæ„ŸæŸ“ |
| Streptococcal bacteraemia | éˆçƒèŒèŒè¡€ç—‡ |
| Enterococcus spp. bacteraemia | è…¸çƒèŒèŒè¡€ç—‡ |
| Fungaemia (candidaemia) | çœŸèŒè¡€ç—‡ï¼ˆå¿µç èŒè¡€ç—‡ï¼‰ |
| Surgical site infections | æ‰‹è¡“éƒ¨ä½æ„ŸæŸ“ |
| Paediatric bacteraemia | å°å…’èŒè¡€ç—‡ |
| Critical care bloodstream infections | åŠ è­·ç—…æˆ¿è¡€æµæ„ŸæŸ“ |

**ESPAUR å ±å‘Š**ï¼šè‹±æ ¼è˜­æŠ—å¾®ç”Ÿç‰©è—¥ç‰©ä½¿ç”¨èˆ‡æŠ—è—¥æ€§ç›£æ¸¬è¨ˆç•«å¹´åº¦å ±å‘Šï¼Œæä¾›æŠ—ç”Ÿç´ è™•æ–¹è¶¨å‹¢ã€ç´°èŒæŠ—è—¥æ€§ç›£æ¸¬çµæœï¼Œä»¥åŠæŠ—å¾®ç”Ÿç‰©ç®¡ç†è¨ˆç•«å¯¦æ–½ç‹€æ³ã€‚

**è‰±é›£æ¢­èŒæ ¸ç³–åˆ†å‹ç¶²çµ¡ï¼ˆCDRNï¼‰å ±å‘Š**ï¼šåˆ†æ C. difficile æ ¸ç³–å‹æµè¡Œè¶¨å‹¢ï¼Œç ”ç©¶ CDI æ„ŸæŸ“ç‡ä¸Šå‡ç›¸é—œå› ç´ ã€‚

ä¾†æºï¼š
- uk_ukhsa_updates/surveillance/2026-02-24-*.mdï¼ˆå¤šé …ç›£æ¸¬å ±å‘Šï¼‰**[æœ¬é€±æ–°å¢]**
- uk_ukhsa_updates/research/2026-02-24-clostridioides-difficile-ribotyping-network-cdrn-report.md **[æœ¬é€±æ–°å¢]**

#### A ç¾¤éˆçƒèŒå­£ç¯€æ€§ç›£æ¸¬ â€” è‹±åœ‹
{: #gas-surveillance}

<p class="key-answer" data-question="A ç¾¤éˆçƒèŒæ„ŸæŸ“æœ‰å“ªäº›è¡¨ç¾">A ç¾¤éˆçƒèŒå¯å°è‡´è¼•ç—‡å¦‚çŒ©ç´…ç†±ã€å’½ç‚ï¼Œä»¥åŠåš´é‡çš„ä¾µè¥²æ€§æ„ŸæŸ“ï¼ˆiGASï¼‰å¦‚æ•—è¡€ç—‡ã€å£æ­»æ€§ç­‹è†œç‚ç­‰ã€‚</p>

UKHSA æ–¼ 2 æœˆ 24 æ—¥ç™¼å¸ƒ 2024-2025 å¹´åº¦ A ç¾¤éˆçƒèŒå­£ç¯€æ€§æ´»å‹•å ±å‘Šï¼š

**ç›£æ¸¬å…§å®¹**ï¼š
- çŒ©ç´…ç†±ï¼ˆscarlet feverï¼‰ç–¾ç—…é€šå ±æ•¸æ“š
- ä¾µè¥²æ€§ A ç¾¤éˆçƒèŒï¼ˆiGASï¼‰æ„ŸæŸ“ç›£æ¸¬çµæœ
- ä¸åŒå¹´é½¡ç¾¤çš„ç™¼ç—…ç‡
- å­£ç¯€æ€§æµè¡Œæ¨¡å¼åˆ†æ

ä¾†æºï¼šuk_ukhsa_updates/surveillance/2026-02-24-group-a-streptococcal-infections-seasonal-activity-in-england-2024-to-2025.md **[æœ¬é€±æ–°å¢]**

#### å¸¶ç‹€ç–±ç–¹ç–«è‹—æ¥ç¨®å‘¼ç±² â€” è‹±åœ‹
{: #shingles-vaccine}

<p class="key-answer" data-question="è‹±åœ‹å¸¶ç‹€ç–±ç–¹ç–«è‹—æ¥ç¨®ç‡å¦‚ä½•">UKHSA æŒ‡å‡ºç¬¦åˆå…è²»å¸¶ç‹€ç–±ç–¹ç–«è‹—æ¥ç¨®è³‡æ ¼çš„æ°‘çœ¾ä¸­ï¼Œåªæœ‰ä¸åˆ° 50% å·²æ¥ç¨®ï¼Œå‘¼ç±²æ•¸ç™¾è¬ç¬¦åˆæ¢ä»¶è€…å„˜é€Ÿæ¥ç¨®ã€‚</p>

UKHSA æ–¼ 2 æœˆ 26 æ—¥å‘¼ç±²ç¬¦åˆè³‡æ ¼çš„æ°‘çœ¾æ¥ç¨®å¸¶ç‹€ç–±ç–¹ç–«è‹—ï¼š

**æ ¸å¿ƒç™¼ç¾**ï¼š
- ç¬¦åˆå…è²»æ¥ç¨®æ¢ä»¶è€…ä¸­ï¼Œåªæœ‰ä¸åˆ° 50% å·²æ¥ç¨®
- æ•¸ç™¾è¬äººä»é¢è‡¨å¸¶ç‹€ç–±ç–¹åŠå…¶ä½µç™¼ç—‡é¢¨éšª

**å¸¶ç‹€ç–±ç–¹ç°¡ä»‹**ï¼š
- ç”±æ°´ç—˜-å¸¶ç‹€ç–±ç–¹ç—…æ¯’ï¼ˆvaricella-zoster virusï¼‰å†æ´»åŒ–å¼•èµ·
- ä¸»è¦å½±éŸ¿è€å¹´äººå’Œå…ç–«åŠ›è¼ƒå¼±çš„æ—ç¾¤
- å¯å°è‡´åŠ‡çƒˆç–¼ç—›ã€çš®ç–¹
- å¯èƒ½å¼•ç™¼å¸¶ç‹€ç–±ç–¹å¾Œç¥ç¶“ç—›ï¼ˆpostherpetic neuralgiaï¼‰ç­‰é•·æœŸä½µç™¼ç—‡

**Shingrix ç–«è‹—è©•ä¼°å ±å‘Š**ï¼š
UKHSA åŒæ—¥ç™¼å¸ƒ Shingrix å¸¶ç‹€ç–±ç–¹ç–«è‹—æ¥ç¨®è¨ˆåŠƒè©•ä¼°å ±å‘Šï¼Œæ¶µè“‹ 2023/24 å’Œ 2024/25 å­¸å¹´åº¦çš„å¯¦æ–½æˆæ•ˆï¼Œåˆ†æç–«è‹—æ¥ç¨®è¦†è“‹ç‡å’Œè¨ˆåŠƒå¯¦æ–½æŒ‘æˆ°ã€‚

ä¾†æºï¼š
- uk_ukhsa_updates/guidance/2026-02-26-millions-eligible-free-shingles-vaccine-urged-come-forward.md **[2/26 æ›´æ–°]**
- uk_ukhsa_updates/research/2026-02-26-shingles-immunisation-programme-shingrix-evaluation-reports.md **[2/26 æ›´æ–°]**

##### æ­·å²åƒè€ƒ [èªæ„æœå°‹]

| æ—¥æœŸ | æ¨™é¡Œ | ä¾†æº | ç›¸é—œåˆ†æ•¸ |
|------|------|------|----------|
| 2026-02-26 | Shingles immunisation programme Shingrix evaluation reports | UKHSA | 0.70 |
| 2022-01-20 | Use of Recombinant Zoster Vaccine in Immunocompromised Adults | US CDC MMWR | 0.53 |
| 2021-06-17 | QuickStats: Percentage of Adults Aged 50+ Who Ever Received Shingles Vaccination | US CDC MMWR | 0.51 |

#### è‹±åœ‹ 2026-2027 å¹´æµæ„Ÿå…ç–«è¨ˆç•«
{: #uk-flu-programme}

<p class="key-answer" data-question="è‹±åœ‹ 2026-2027 å¹´æµæ„Ÿè¨ˆç•«é‡å°å“ªäº›äººç¾¤">è‹±åœ‹æµæ„Ÿå…ç–«æ¥ç¨®è¨ˆç•«é‡å° 65 æ­²ä»¥ä¸Šã€å­•å©¦ã€é†«è­·äººå“¡ã€2-17 æ­²å…’ç«¥ã€æ…¢æ€§ç—…æ‚£ã€å…ç–«åŠŸèƒ½ä½ä¸‹è€…åŠé•·ç…§æ©Ÿæ§‹ä½æ°‘æä¾›å…è²»æ¥ç¨®ã€‚</p>

UKHSA æ–¼ 2 æœˆ 26 æ—¥ç™¼å¸ƒ 2026-2027 å¹´åº¦åœ‹å®¶æµæ„Ÿå…ç–«æ¥ç¨®è¨ˆåŠƒï¼š

**ç¬¦åˆå…è²»æ¥ç¨®çš„æ—ç¾¤**ï¼š
- 65 æ­²ä»¥ä¸Šè€å¹´äºº
- é†«ç™‚å’Œç¤¾æœƒç…§è­·å·¥ä½œè€…
- å­•å©¦
- 2-17 æ­²å…’ç«¥èˆ‡é’å°‘å¹´
- æ…¢æ€§ç–¾ç—…é«˜é¢¨éšªæ—ç¾¤ï¼ˆç³–å°¿ç—…ã€å¿ƒè‡Ÿç—…ã€å‘¼å¸ç³»çµ±ç–¾ç—…ç­‰ï¼‰
- å…ç–«åŠŸèƒ½ä½ä¸‹è€…
- é•·æœŸç…§è­·æ©Ÿæ§‹ä½æ°‘

**æµæ„Ÿç–«è‹—æ¥ç¨®ç‡ç›£æ¸¬**ï¼ˆ2025-2026 å¹´åº¦ï¼‰ï¼š
UKHSA åŒæ—¥ç™¼å¸ƒé†«è­·äººå“¡åŠå­¸é½¡å…’ç«¥æµæ„Ÿç–«è‹—æ¥ç¨®ç‡æ¯æœˆæ•¸æ“šï¼Œç‚ºè©•ä¼°æµæ„Ÿå…ç–«è¨ˆç•«æˆæ•ˆæä¾›é—œéµæŒ‡æ¨™ã€‚

ä¾†æºï¼š
- uk_ukhsa_updates/guidance/2026-02-26-national-flu-immunisation-programme-plan-2026-to-2027.md **[2/26 æ›´æ–°]**
- uk_ukhsa_updates/surveillance/2026-02-26-seasonal-influenza-vaccine-uptake-frontline-healthcare-workers.md **[2/26 æ›´æ–°]**
- uk_ukhsa_updates/surveillance/2026-02-26-seasonal-influenza-vaccine-uptake-children-school-age.md **[2/26 æ›´æ–°]**

##### æ­·å²åƒè€ƒ [èªæ„æœå°‹]

| æ—¥æœŸ | æ¨™é¡Œ | ä¾†æº | ç›¸é—œåˆ†æ•¸ |
|------|------|------|----------|
| 2026-01-29 | Seasonal influenza vaccine uptake in GP patients: monthly data 2025-2026 | UKHSA | 0.65 |
| 2022-10-20 | Influenza and COVID-19 Vaccination Coverage Among HCWs - US, 2021-22 | US CDC MMWR | 0.56 |
| 2023-12-21 | Influenza, COVID-19, RSV Vaccination Coverage - US, Fall 2023 | US CDC MMWR | 0.55 |

### æŒçºŒç›£æ¸¬

#### æµæ„Ÿï¼ˆInfluenzaï¼‰â€” å°ç£æ”¿ç­–èª¿æ•´
{: #influenza-policy}

<p class="key-answer" data-question="å°ç£æµæ„Ÿæ”¿ç­–æœ‰ä½•èª¿æ•´">å…¬è²»æµæ„ŸæŠ—ç—…æ¯’è—¥åŠ‘æ“´å¤§ä½¿ç”¨æ¢ä»¶æ–¼ 2/28 æˆªæ­¢ï¼Œ3/1 èµ·æ¢å¾©æ­£å¸¸ç”¨è—¥è³‡æ ¼ï¼›æ–°å† ç–«è‹—æ“´å¤§å…¨æ°‘æ¥ç¨®å»¶é•·è‡³ 4/30ã€‚</p>

ç–¾ç®¡ç½² 2 æœˆ 24 æ—¥å®£å¸ƒæµæ„Ÿç›¸é—œæ”¿ç­–èª¿æ•´ï¼š

**æµæ„Ÿç–«æƒ…ç¾æ³**ï¼š
- ç¬¬ 7 é€±é¡æµæ„Ÿé–€æ€¥è¨ºï¼š58,075 äººæ¬¡
- æ˜¥ç¯€é€£å‡æ–°å¢ï¼š5 ä¾‹æµæ„Ÿä½µç™¼é‡ç—‡ã€2 ä¾‹æ­»äº¡
- ç–«æƒ…è¶¨å‹¢ï¼šå‘ˆä¸‹é™è¶¨å‹¢ï¼Œæ˜¥ç¯€å‰å¾Œå‡æœªé€²å…¥æµè¡ŒæœŸ
- å…¬è²»ç–«è‹—æ¥ç¨®ï¼šç´„ 674.8 è¬äººæ¬¡ï¼Œåƒ…é¤˜ç´„ 8 è¬åŠ‘

**æ”¿ç­–èª¿æ•´**ï¼š

| é …ç›® | è®Šæ›´å…§å®¹ | æ—¥æœŸ |
|------|----------|------|
| å…¬è²»æµæ„ŸæŠ—ç—…æ¯’è—¥åŠ‘ | æ“´å¤§ä½¿ç”¨æ¢ä»¶æˆªæ­¢ | 2026/2/28 |
| å…¬è²»æµæ„ŸæŠ—ç—…æ¯’è—¥åŠ‘ | æ¢å¾©æ­£å¸¸ç”¨è—¥è³‡æ ¼ï¼ˆ10 é …æ¢ä»¶ï¼‰ | 2026/3/1 |
| æ–°å† ç–«è‹— | æ“´å¤§å…¨æ°‘æ¥ç¨®å»¶é•· | è‡³ 2026/4/30 |

**æ¢å¾©å¾Œçš„ 10 é …å…¬è²»è—¥åŠ‘ç”¨è—¥æ¢ä»¶**ï¼š
1. æµæ„Ÿä½µç™¼é‡ç—‡é€šå ±ç—…ä¾‹
2. æ–°å‹ A å‹æµæ„Ÿé€šå ±ç—…ä¾‹
3. å­•å©¦åŠç”¢å¾Œå…©é€±å…§ä¹‹å©¦å¥³
4. æœªæ»¿ 5 æ­²åŠ 65 æ­²ä»¥ä¸Šä¹‹é¡æµæ„Ÿæ‚£è€…
5. ç¢ºè¨ºæˆ–ç–‘ä¼¼æµæ„Ÿä½é™¢ï¼ˆå«æ€¥è¨ºå¾…åºŠï¼‰
6. é‡å¤§å‚·ç—…ã€å…ç–«ä¸å…¨æˆ–æµæ„Ÿé«˜é¢¨éšªæ…¢æ€§ç–¾ç—…æ‚£è€…
7. è‚¥èƒ–ä¹‹é¡æµæ„Ÿæ‚£è€…ï¼ˆBMIâ‰§30ï¼‰
8. é¡æµæ„Ÿç¾¤èšäº‹ä»¶ç¶“é˜²ç–«é†«å¸«èªå®šéœ€ç”¨è—¥è€…
9. æ–°å‹ A å‹æµæ„Ÿæ¥µå¯èƒ½/ç¢ºå®šç—…ä¾‹ä¹‹å¯†åˆ‡æ¥è§¸è€…
10. å‹•ç‰©æµæ„Ÿç™¼ç”Ÿå ´æ‰€æ’²æ®ºæ¸…å ´å·¥ä½œäººå“¡

**åœ‹éš›ç–«æƒ…**ï¼š
- éŸ“åœ‹ã€æ—¥æœ¬ï¼šæµæ„Ÿç–«æƒ…è™•é«˜é»
- å…¨çƒä¸»è¦å‹åˆ¥ï¼šA å‹ç‚ºä¸»ï¼ŒB å‹å æ¯”ä¸Šå‡

ä¾†æºï¼š
- tw_cdc_alerts/policy/2026-02-24-flu-antiviral-policy-changes.md **[æœ¬é€±æ–°å¢]**
- tw_cdc_alerts/medical_advisory/2026-02-24-flu-antiviral-policy-medical-advisory.md **[æœ¬é€±æ–°å¢]**

##### æ­·å²åƒè€ƒ [èªæ„æœå°‹]

| æ—¥æœŸ | æ¨™é¡Œ | ä¾†æº | ç›¸é—œåˆ†æ•¸ |
|------|------|------|----------|
| 2026-02-05 | National flu and COVID-19 surveillance reports: 2025 to 2026 season | UKHSA | 0.56 |
| 2025-09-25 | Pediatric Influenza-Associated Encephalopathy | US CDC MMWR | 0.54 |

#### éº»ç–¹ï¼ˆMeaslesï¼‰

- å°ç£é¦–ä¾‹å¢ƒå¤–ç§»å…¥ç—…ä¾‹æ¥è§¸è€…ç›£æ¸¬æœŸå·²æ–¼ 2/28 çµæŸï¼Œæœªæœ‰æ–°å¢ç—…ä¾‹
- å…¨çƒç–«æƒ…ä»ç„¶åš´å³»

#### ç™¾æ—¥å’³ï¼ˆPertussisï¼‰

- å°ç£é¦–ä¾‹ç™¾æ—¥å’³ç—…ä¾‹å®¶åº­æ¥è§¸è€…æŒçºŒç›£æ¸¬è‡³ 3/4
- å…¨çƒç–«æƒ…åš´å³»ï¼Œæ—¥æœ¬å»å¹´é€¾ 8 è¬ä¾‹

#### çŒ´ç—˜ï¼ˆMpoxï¼‰

- UKHSA æŒçºŒæ›´æ–° clade Ib åŠ clade IIb æµè¡Œç—…å­¸æ¦‚æ³
- å…¨çƒç¶­æŒè­¦æˆ’

#### ç«‹ç™¾ç—…æ¯’ç—…ï¼ˆNipah Virus Diseaseï¼‰

- å°åº¦è¥¿å­ŸåŠ æ‹‰é‚¦ç–«æƒ…æŒçºŒç›£æ¸¬
- å°ç£é è¨ˆ 3 æœˆä¸­æ­£å¼å°‡ã€Œç«‹ç™¾ç—…æ¯’æ„ŸæŸ“ç—‡ã€åˆ—ç‚ºç¬¬äº”é¡æ³•å®šå‚³æŸ“ç—…

### é¢¨éšªè©•ä¼°æ›´æ–°

#### ECDC æ­ç›Ÿåƒè€ƒå¯¦é©—å®¤ææ¡ˆï¼ˆæŒçºŒè¿½è¹¤ï¼‰

ä¸Šé€± ECDC å»ºè­°åœ¨å››å€‹é ˜åŸŸå»ºç«‹æ–°çš„æ­ç›Ÿåƒè€ƒå¯¦é©—å®¤ï¼ˆè‰±é›£æ¢­èŒã€æŠ—è—¥æ€§æ·‹ç—…ã€çµæ ¸ç—…ã€ä¾µè¥²æ€§ç´°èŒç–¾ç—…ï¼‰ï¼Œæœ¬é€± UKHSA ç™¼å¸ƒè‰±é›£æ¢­èŒæ ¸ç³–åˆ†å‹ç¶²çµ¡å ±å‘Šï¼Œé¡¯ç¤ºæ­æ´²å° C. difficile ç›£æ¸¬çš„é‡è¦–ã€‚

ä¾†æºï¼šecdc_cdtr/guidance/2026-02-23-ecdc-proposes-new-eu-reference-laboratories.md

---

## å€åŸŸå‹•æ…‹

### æ­æ´² (ECDC)

**ç¬¬ 9 é€±ä¸»è¦å‹•æ…‹ï¼ˆ2026/2/22-2/25ï¼‰**

| å¨è„…é …ç›® | ç‹€æ…‹ |
|----------|------|
| æ­ç›Ÿåƒè€ƒå¯¦é©—å®¤ææ¡ˆ | æŒçºŒè¿½è¹¤ä¸­ **[ä¸Šé€±æ–°å¢]** |
| è«¾ç¾…ç—…æ¯’ | è‹±åœ‹ç–«æƒ…é”è¿‘ 5 å¹´æœ€é«˜ |
| ç¾©å¤§åˆ©å†¬å­£å¥§é‹ | å‚³å‡ºè«¾ç¾…ç—…æ¯’ç¾¤èšç–«æƒ… |
| æŠ—å¾®ç”Ÿç‰©æŠ—è—¥æ€§ | é£Ÿæºæ€§ç´°èŒæŠ—è—¥æ€§è­¦å‘ŠæŒçºŒé—œæ³¨ |

### è‹±åœ‹ (UKHSA)

**æœ¬é€±é‡è¦æ›´æ–°**

| é¡å‹ | äº‹ä»¶ | æ—¥æœŸ |
|------|------|------|
| **æŒ‡å¼•ç™¼å¸ƒ** | **å¸¶ç‹€ç–±ç–¹ç–«è‹—æ¥ç¨®å‘¼ç±²** | **2/26** |
| **ç ”ç©¶å ±å‘Š** | **Shingrix ç–«è‹—è©•ä¼°å ±å‘Š** | **2/26** |
| **æŒ‡å¼•ç™¼å¸ƒ** | **2026-2027 å¹´æµæ„Ÿå…ç–«è¨ˆç•«** | **2/26** |
| **ç›£æ¸¬å ±å‘Š** | **é†«è­·äººå“¡æµæ„Ÿç–«è‹—æ¥ç¨®ç‡** | **2/26** |
| **ç›£æ¸¬å ±å‘Š** | **å­¸é½¡å…’ç«¥æµæ„Ÿç–«è‹—æ¥ç¨®ç‡** | **2/26** |
| ç›£æ¸¬å ±å‘Š | ESPAUR æŠ—å¾®ç”Ÿç‰©æŠ—è—¥æ€§å¹´åº¦å ±å‘Š | 2/24 |
| ç›£æ¸¬å ±å‘Š | A ç¾¤éˆçƒèŒå­£ç¯€æ€§æ´»å‹•å ±å‘Š | 2/24 |
| ç ”ç©¶å ±å‘Š | è‰±é›£æ¢­èŒæ ¸ç³–åˆ†å‹ç¶²çµ¡å ±å‘Š | 2/24 |
| ç›£æ¸¬å ±å‘Š | MRSA/MSSA/å¤§è…¸æ¡¿èŒç­‰èŒè¡€ç—‡å¹´åº¦æ•¸æ“š | 2/24 |

**é‡é»è­°é¡Œ**ï¼š
- **å¸¶ç‹€ç–±ç–¹ç–«è‹—**ï¼šå‘¼ç±²æ•¸ç™¾è¬ç¬¦åˆæ¢ä»¶è€…æ¥ç¨®ï¼Œæ¥ç¨®ç‡ä¸åˆ° 50%
- **æµæ„Ÿå…ç–«è¨ˆç•«**ï¼šç™¼å¸ƒ 2026-2027 å¹´åº¦è¨ˆç•«æŒ‡å¼•
- **ç–«è‹—æ¥ç¨®ç‡ç›£æ¸¬**ï¼šé†«è­·äººå“¡åŠå­¸é½¡å…’ç«¥æµæ„Ÿç–«è‹—æ¥ç¨®æ•¸æ“š
- **é†«ç™‚æ©Ÿæ§‹æ„ŸæŸ“ç›£æ¸¬**ï¼šç™¼å¸ƒå¤šé …ç›£æ¸¬å ±å‘Š
- **æŠ—å¾®ç”Ÿç‰©æŠ—è—¥æ€§ç›£æ¸¬**ï¼šESPAUR å¹´åº¦å ±å‘Š

### äºå¤ªåœ°å€

**å°ç£ (tw_cdc_alerts)**

| äº‹ä»¶ | ç‹€æ…‹ | å‚™è¨» |
|------|------|------|
| **ç™»é©ç†±å¢ƒå¤–ç§»å…¥** | **19 ä¾‹ï¼ˆæˆªè‡³ 2/25ï¼‰** | **å°å°¼ 6 ä¾‹æœ€å¤š** **[2/26 æ›´æ–°]** |
| **å…¬è²»ç–«è‹—è™•ç½®è²»èª¿å‡** | **3/1 ç”Ÿæ•ˆ** | **6æ­²ä»¥ä¸‹ 200 å…ƒã€å…¶ä»– 150 å…ƒ** **[2/26 æ›´æ–°]** |
| è«¾ç¾…ç—…æ¯’ç¾¤èš | è¿‘å››é€± 122 èµ· | é¤é£²æ—…å®¿æ¥­ç‚ºä¸» |
| è…¸ç—…æ¯’é–‹å­¸è­¦ç¤º | ç™¼å¸ƒè¡›æ•™ | ç¤¾å€ä»¥å…‹æ²™å¥‡ A6 å‹ç‚ºå¤š |
| æµæ„Ÿæ”¿ç­–èª¿æ•´ | 2/28 æˆªæ­¢æ“´å¤§ç”¨è—¥ | 3/1 æ¢å¾©æ­£å¸¸æ¢ä»¶ |
| æ–°å† ç–«è‹— | å»¶é•·è‡³ 4/30 | æ“´å¤§å…¨æ°‘æ¥ç¨® |
| éº»ç–¹ç›£æ¸¬ | 2/28 çµæŸ | 400 åæ¥è§¸è€…å·²å®Œæˆ |
| ç™¾æ—¥å’³ç›£æ¸¬ | æŒçºŒè‡³ 3/4 | å®¶åº­æ¥è§¸è€… |

**æ—¥æœ¬ã€éŸ“åœ‹**ï¼š
- æµæ„Ÿç–«æƒ…è™•é«˜é»
- è«¾ç¾…ç—…æ¯’ç–«æƒ…é”è¿‘ 5 å¹´æœ€é«˜

**ä¸­åœ‹ã€è¶Šå—**ï¼š
- è…¸ç—…æ¯’éœ€æ³¨æ„ EV71 å‹é‡ç—‡ç—…ä¾‹

---

## æ—…éŠå¥åº·å»ºè­°

### è…¸èƒƒé“å‚³æŸ“ç—…é é˜²

<p class="key-answer" data-question="å¦‚ä½•é é˜²æ—…éŠæœŸé–“è…¸èƒƒé“æ„ŸæŸ“">æ³¨æ„é£²é£Ÿè¡›ç”Ÿã€é¿å…ç”Ÿé£Ÿç”Ÿé£²ã€å‹¤æ´—æ‰‹ï¼Œè¿”åœ‹å¾Œå¦‚æœ‰è…¹ç€‰å˜”åç—‡ç‹€æ‡‰å„˜é€Ÿå°±é†«ä¸¦å‘ŠçŸ¥æ—…éŠå²ã€‚</p>

<ol class="actionable-steps">
<li>å¦‚å»å¾Œã€é€²é£Ÿå‰ä»¥è‚¥çš‚æ­£ç¢ºæ´—æ‰‹</li>
<li>é¿å…ç”Ÿé£Ÿç”Ÿé£²ï¼Œé£Ÿç‰©æ¾ˆåº•ç…®ç†Ÿ</li>
<li>é¸æ“‡è¡›ç”Ÿæ¢ä»¶è‰¯å¥½çš„é¤å»³</li>
<li>è¿”åœ‹å¾Œå¦‚æœ‰è…¹ç€‰ã€å˜”åç—‡ç‹€æ‡‰å„˜é€Ÿå°±é†«</li>
<li>ä¸»å‹•å‘ŠçŸ¥é†«å¸«æ—…éŠå²åŠé£²é£Ÿå²</li>
</ol>

### Level 2 - åŠ å¼·é˜²è­·æªæ–½

| ç›®çš„åœ° | ç–¾ç—… | å»ºè­° |
|--------|------|------|
| è˜‡åˆ©å—ã€å¡å¸­çˆ¾ | å±ˆå…¬ç—… (Chikungunya) | é˜²èšŠæªæ–½ |
| è¿¦ç´ã€è³´æ¯”ç‘äº | çŒ´ç—˜ (Clade II) | é¿å…æ¥è§¸ç—…æ‚£ã€é‡ç”Ÿå‹•ç‰© |
| ä¸­åœ‹ï¼ˆ15çœå¸‚ï¼‰ã€æŸ¬åŸ”å¯¨ | ç¦½æµæ„Ÿ H5N1 | é¿å…æ¥è§¸ç¦½é³¥ |
| è¶Šå—ã€å°å°¼ã€å°åº¦ç­‰ 7 åœ‹ | éº»ç–¹ | ç¢ºèª MMR ç–«è‹—æ¥ç¨®ç‹€æ…‹ |

### Level 1 - ä¸€èˆ¬é˜²è­·æªæ–½

| ç›®çš„åœ° | ç–¾ç—… | å»ºè­° |
|--------|------|------|
| å°å°¼ã€è²å¾‹è³“ã€è¶Šå—ã€æ³°åœ‹ã€é¦¬ä¾†è¥¿äºã€æ–¯é‡Œè˜­å¡ã€å°åº¦ã€é¦¬çˆ¾åœ°å¤« | ç™»é©ç†± | é˜²èšŠæªæ–½ã€è¿”åœ‹å¾Œ 2 é€±æ³¨æ„ç—‡ç‹€ **[2/26 æ›´æ–°]** |
| å…¨çƒå¤šåœ‹ | ç™»é©ç†± | é˜²èšŠæªæ–½ |
| å…¨çƒå¤šåœ‹ | éº»ç–¹ | ç¢ºèª MMR ç–«è‹—æ¥ç¨®ç‹€æ…‹ |
| å…¨çƒå¤šåœ‹ | è«¾ç¾…ç—…æ¯’ | æ³¨æ„é£²é£Ÿè¡›ç”Ÿ |

### ç«‹ç™¾ç—…æ¯’æµè¡Œå€æ³¨æ„äº‹é …

**å°åº¦è¥¿å­ŸåŠ æ‹‰é‚¦ã€å–€æ‹‰æ‹‰é‚¦ï¼›å­ŸåŠ æ‹‰**ï¼š
- é¿å…æ¥è§¸è™è æˆ–è±¬éš»
- é¿å…é£²ç”¨ç”Ÿæ¤°æ£—æ¨¹æ±åŠé£Ÿç”¨å¯èƒ½è¢«æ±¡æŸ“çš„æ°´æœ
- ä¿æŒè‰¯å¥½æ‰‹éƒ¨è¡›ç”Ÿ

---

## å…¬å…±è¡›ç”ŸæŒ‡å¼•

### è«¾ç¾…ç—…æ¯’é˜²æ²»æŒ‡å¼•

<p class="key-answer" data-question="è«¾ç¾…ç—…æ¯’å¦‚ä½•å‚³æ’­">è«¾ç¾…ç—…æ¯’å‚³æŸ“åŠ›å¼·ï¼Œå¯é€éé£Ÿå…¥å—æ±¡æŸ“é£Ÿç‰©æˆ–é£²æ°´ã€æ¥è§¸æ±¡æŸ“ç‰©é«”è¡¨é¢ã€å¸å…¥ç—…äººå˜”åç‰©æˆ–æ’æ³„ç‰©é£›æ²«è€Œæ„ŸæŸ“ã€‚</p>

**è«¾ç¾…ç—…æ¯’ç‰¹æ€§**ï¼š
- å‚³æŸ“åŠ›å¼·ï¼Œä½ç—…æ¯’é‡å³å¯è‡´ç—…
- æ½›ä¼æœŸç´„ 10-50 å°æ™‚
- ä»»ä½•å¹´é½¡å±¤éƒ½å¯èƒ½æ„ŸæŸ“

**è‡¨åºŠç—‡ç‹€**ï¼š
- æ°´ç€‰åŠå˜”åï¼ˆä¸»è¦ï¼‰
- å™å¿ƒã€ç™¼ç‡’ã€é ­ç—›
- è…¹éƒ¨ç—™æ”£ã€èƒƒç—›ã€è‚Œè‚‰é…¸ç—›

**ç’°å¢ƒæ¶ˆæ¯’**ï¼š

| å°è±¡ | æ¼‚ç™½æ°´æ¿ƒåº¦ | ç¨€é‡‹æ¯”ä¾‹ |
|------|-----------|----------|
| ä¸€èˆ¬ç’°å¢ƒï¼ˆåœ°é¢ã€é–€æŠŠï¼‰ | 1,000 ppm | 20 c.c. æ¼‚ç™½æ°´ + 1 å…¬å‡æ¸…æ°´ |
| å˜”åç‰©ã€æ’æ³„ç‰© | 5,000 ppm | 100 c.c. æ¼‚ç™½æ°´ + 1 å…¬å‡æ¸…æ°´ |

**æ³¨æ„**ï¼šç¨€é‡‹æ¼‚ç™½æ°´æ‡‰ç•¶å¤©é…è£½ä¸¦æ¨™ç¤ºæ—¥æœŸï¼ŒåŠ è“‹é¿å…é™½å…‰ç…§å°„ï¼Œæœªä½¿ç”¨å®Œæ‡‰æ–¼ 24 å°æ™‚å¾Œä¸Ÿæ£„ã€‚

### è…¸ç—…æ¯’é˜²æ²»æŒ‡å¼•

<p class="key-answer" data-question="é…’ç²¾èƒ½æ®ºæ­»è…¸ç—…æ¯’å—">é…’ç²¾å°è…¸ç—…æ¯’çš„æ¯’æ®ºæ•ˆæœæœ‰é™ï¼Œæ‡‰ä½¿ç”¨è‚¥çš‚æ´—æ‰‹æˆ–å«æ°¯æ¼‚ç™½æ°´ï¼ˆ500 ppmï¼‰é€²è¡Œç’°å¢ƒæ¶ˆæ¯’ã€‚</p>

**æ´—æ‰‹äº”æ­¥é©Ÿ**ï¼šæ¿•ã€æ“ã€æ²–ã€æ§ã€æ“¦

**ç’°å¢ƒæ¶ˆæ¯’**ï¼š500 ppm å«æ°¯æ¼‚ç™½æ°´ï¼ˆ10 å…¬å‡æ¸…æ°´ + 100 æ¯«å‡å«æ°¯æ¼‚ç™½æ°´ï¼‰

### æµæ„Ÿé˜²æ²»æŒ‡å¼•

<ol class="actionable-steps">
<li>65 æ­²ä»¥ä¸Šé•·è€…ã€æ…¢æ€§ç—…æ‚£æŠŠæ¡å…¬è²»ç–«è‹—æœ€å¾Œæ©Ÿæœƒ</li>
<li>å‡ºç¾å±éšªå¾µå…†ï¼ˆå‘¼å¸æ€¥ä¿ƒã€èƒ¸ç—›ã€æ„è­˜æ”¹è®Šç­‰ï¼‰æ‡‰å„˜é€Ÿå°±é†«</li>
<li>è½å¯¦å‹¤æ´—æ‰‹ã€ä½©æˆ´å£ç½©ã€å’³å—½ç¦®ç¯€</li>
<li>ç”Ÿç—…åœ¨å®¶ä¼‘æ¯ï¼Œé¿å…å‡ºå…¥äººæ½®æ“æ“ å ´æ‰€</li>
</ol>

---

## è³‡æ–™ä¾†æº

æœ¬å ±å‘ŠåŸºæ–¼ä»¥ä¸‹ä¾†æºï¼š
- ECDC å‚³æŸ“ç—…å¨è„…å ±å‘Š (ecdc_cdtr)
- WHO ç–¾ç—…ç–«æƒ…æ–°è (who_disease_outbreak_news)
- US CDC å¥åº·è­¦å ±ç¶²çµ¡ (us_cdc_han)
- US CDC MMWR é€±å ± (us_cdc_mmwr)
- US CDC æ—…éŠå¥åº·é€šçŸ¥ (us_travel_health_notices)
- å°ç£ç–¾ç®¡ç½²å…¬å‘Š (tw_cdc_alerts)
- UK Health Security Agency (uk_ukhsa_updates)

### æœ¬é€±å¼•ç”¨è³‡æ–™

**å°ç£ç–¾ç®¡ç½² (tw_cdc_alerts)**
- `medical_advisory/2026-02-26-dengue-fever-importation-risk-alert.md` **[2/26 æ›´æ–°]**
- `policy/2026-02-26-vaccination-fee-adjustment.md` **[2/26 æ›´æ–°]**
- `disease_info/2025-12-01-world-aids-day-2025.md` **[2/26 æ›´æ–°]**
- `domestic_outbreak/2026-02-24-norovirus-outbreak-lunar-new-year.md`
- `disease_info/2026-02-24-entrovirus-prevention-schools.md`
- `policy/2026-02-24-flu-antiviral-policy-changes.md`
- `medical_advisory/2026-02-24-flu-antiviral-policy-medical-advisory.md`

**UK UKHSA (uk_ukhsa_updates)**
- `guidance/2026-02-26-millions-eligible-free-shingles-vaccine-urged-come-forward.md` **[2/26 æ›´æ–°]**
- `guidance/2026-02-26-national-flu-immunisation-programme-plan-2026-to-2027.md` **[2/26 æ›´æ–°]**
- `research/2026-02-26-shingles-immunisation-programme-shingrix-evaluation-reports.md` **[2/26 æ›´æ–°]**
- `surveillance/2026-02-26-seasonal-influenza-vaccine-uptake-frontline-healthcare-workers.md` **[2/26 æ›´æ–°]**
- `surveillance/2026-02-26-seasonal-influenza-vaccine-uptake-children-school-age.md` **[2/26 æ›´æ–°]**
- `guidance/2026-02-26-statistics-at-ukhsa.md` **[2/26 æ›´æ–°]**
- `surveillance/2026-02-24-english-surveillance-programme-antimicrobial-utilisation-and-resistance-espaur-report.md`
- `surveillance/2026-02-24-group-a-streptococcal-infections-seasonal-activity-in-england-2024-to-2025.md`
- `research/2026-02-24-clostridioides-difficile-ribotyping-network-cdrn-report.md`
- `surveillance/2026-02-24-mrsa-bacteraemia-annual-data.md`
- `surveillance/2026-02-24-mssa-bacteraemia-annual-data.md`
- `surveillance/2026-02-24-escherichia-coli-bacteraemia-annual-data.md`
- `surveillance/2026-02-24-klebsiella-species-bacteraemia-annual-data.md`
- `surveillance/2026-02-24-pseudomonas-aeruginosa-bacteraemia-annual-data.md`
- `surveillance/2026-02-24-clostridioides-difficile-infection-annual-data.md`
- `surveillance/2026-02-24-streptococcal-bacteraemia-annual-data-from-voluntary-surveillance.md`
- `surveillance/2026-02-24-enterococcus-spp-bacteraemia-voluntary-surveillance-2023.md`
- `surveillance/2026-02-24-fungaemia-including-candidaemia-annual-data-from-voluntary-surveillance.md`
- `surveillance/2026-02-24-surgical-site-infections-ssi-surveillance-nhs-hospitals-in-england.md`
- `surveillance/2026-02-24-laboratory-surveillance-of-paediatric-bacteraemia-in-england.md`
- `surveillance/2026-02-24-surveillance-of-bloodstream-infections-in-critical-care-england.md`
- `surveillance/2026-02-24-mrsa-mssa-gram-negative-bacteraemia-and-cdi-annual.md`
- `surveillance/2026-02-24-mrsa-mssa-gram-negative-bacteraemia-and-cdi-quarterly.md`
- `surveillance/2026-02-24-mrsa-mssa-gram-negative-bacteraemia-and-cdi-30-day.md`
- `surveillance/2026-02-24-mrsa-mssa-gram-negative-bacteraemia-and-cdi-independent-sector-annual.md`

**ECDC (ecdc_cdtr)**
- `guidance/2026-02-23-ecdc-proposes-new-eu-reference-laboratories.md` **[ä¸Šé€±æ–°å¢ï¼ŒæŒçºŒè¿½è¹¤]**

### èªæ„æœå°‹æŸ¥è©¢ç´€éŒ„

æœ¬å ±å‘Šä½¿ç”¨ Qdrant èªæ„æœå°‹æä¾›æ­·å²è„ˆçµ¡ï¼ŒåŸ·è¡Œä»¥ä¸‹æŸ¥è©¢ï¼š

| æŸ¥è©¢ | æ‰¾åˆ°ç­†æ•¸ | æœ€é«˜ç›¸é—œåˆ†æ•¸ |
|------|----------|--------------|
| dengue fever importation Taiwan | 5 | 0.54 |
| influenza vaccine uptake UK | 5 | 0.65 |
| shingles vaccine Shingrix | 5 | 0.70 |
| influenza flu Taiwan Korea Japan 2026 | 5 | 0.56 |
| norovirus outbreak gastroenteritis 2026 | 5 | 0.66 |
| enterovirus children schools 2026 | 5 | 0.57 |

---

## åˆ†äº«æœ¬é€±å ±

<div class="share-buttons">

[åˆ†äº«è‡³ Facebook](https://www.facebook.com/sharer/sharer.php?u=https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W09){: .btn .btn-outline target="_blank" rel="noopener" }
[åˆ†äº«è‡³ Twitter](https://twitter.com/intent/tweet?url=https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W09&text=EpiAlert%20ç–«æƒ…å¿«è¨Š%202026-W09%20é€±å ±){: .btn .btn-outline target="_blank" rel="noopener" }
[åˆ†äº«è‡³ LINE](https://social-plugins.line.me/lineit/share?url=https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W09){: .btn .btn-outline target="_blank" rel="noopener" }

</div>

---

## å¼•ç”¨æœ¬é€±å ±

<div class="citation-block" style="background: #f6f8fa; border-left: 4px solid #0366d6; padding: 1rem; margin: 1rem 0;">

**APA æ ¼å¼**

<code style="display: block; background: white; padding: 0.5rem; margin-top: 0.5rem; font-size: 0.9rem; word-break: break-all;">
EpiAlert AI ç·¨è¼¯. (2026, February 25). å‚³æŸ“ç—…å¨è„…é€±å ± 2026-W09. EpiAlert ç–«æƒ…å¿«è¨Š. https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W09
</code>

**BibTeX æ ¼å¼**

<pre style="background: white; padding: 0.5rem; margin-top: 0.5rem; font-size: 0.85rem; overflow-x: auto;">
@misc{epialert2026w09,
  author = {{EpiAlert AI ç·¨è¼¯}},
  title = {å‚³æŸ“ç—…å¨è„…é€±å ± 2026-W09},
  year = {2026},
  month = {February},
  day = {25},
  howpublished = {EpiAlert ç–«æƒ…å¿«è¨Š},
  url = {https://epialert.weiqi.kids/Narrator/weekly_digest/2026-W09},
  note = {Accessed: 2026-02-25}
}
</pre>

</div>

<button onclick="window.print()" class="btn btn-outline" style="margin-top: 0.5rem;">
  åˆ—å° / åŒ¯å‡º PDF
</button>

<style>
@media print {
  .site-nav, .site-footer, .share-buttons, .citation-block, button, #region-filter { display: none !important; }
  .main-content { max-width: 100% !important; }
}
</style>

---

*å ±å‘Šç”¢å‡ºæ™‚é–“: 2026-02-26T23:00:00+08:00*
*ä¸‹æ¬¡æ›´æ–°: 2026-03-04 (2026-W10 é€±å ±)*
